Renewed Interest for Galantamine, an 18-Year-Old Alzheimer’s Drug
A recent analysis reveals that people with Alzheimer’s taking Alzheimer’s drug galantamine (Razadyne), approved nearly two decades ago, show moderate cognitive benefits as well…
A recent analysis reveals that people with Alzheimer’s taking Alzheimer’s drug galantamine (Razadyne), approved nearly two decades ago, show moderate cognitive benefits as well…
UPDATE: 3 March 2024, 8:22 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Image: Aduhelm, Biogen/AP. “The approach I’ve been taking is that each decision about whether or not to offer this as a treatment has to…
Looking for answers about Alzheimer’s treatment Aduhelm (generic name aducanumab)? Here’s a primer on what it is, what it does, and more, according to…
“Historic moment:” Today, the FDA gave Biogen’s investigational Alzheimer’s drug aducanumab its approval, with the requirement that they conduct a post-approval trial. UPDATE: 3…
As part of our BrainTalk series, Being Patient spoke with Sandra Kooij about the symptoms and treatment options of ADHD for older adults and…
Pharmaceutical companies are making plans to leverage the emerging technology of quantum computing in hopes of accelerating the search for the next Alzheimer’s treatment….
Dementia is notoriously difficult to accurately diagnose. Parkinson’s disease dementia and Lewy body dementia can be especially hard to tell apart, even for experts….
Melissa J. Armstrong, associate professor of neurology at the University of Floria, discusses the early signs of Lewy body dementia and the importance of…
As part of our BrainTalk series, newscaster Genevieve Glass speaks with Dr. Michael Geschwind about the causes of rapidly progressive dementias — relatively uncommon…
In search of an animal model more comparable to the human brain, Alzheimer’s researchers are turning from mice to monkeys. Animal testing remains controversial,…
As part of our LiveTalk series, Being Patient spoke with John Gastil and movement disorder specialist Dr. Zoltan Mari about the symptoms, diagnosis and…
(UPDATED Sat. March 13, 2021) In January, excitement rippled through the Alzheimer’s community with drugmaker Eli Lilly and Company’s announcement that their experimental drug…
A new approach to Alzheimer’s — a pill containing a key feature of human cells called mitochondria — is being developed to treat the…
As part of our BrainTalk series, Being Patient spoke with Jack Price, professor of developmental neurobiology at King’s College London, about how stem cell…